125 related articles for article (PubMed ID: 30917321)
1. GALNT3 Maintains the Epithelial State in Trophoblast Stem Cells.
Raghu D; Mobley RJ; Shendy NAM; Perry CH; Abell AN
Cell Rep; 2019 Mar; 26(13):3684-3697.e7. PubMed ID: 30917321
[TBL] [Abstract][Full Text] [Related]
2. MAP3K4 Controls the Chromatin Modifier HDAC6 during Trophoblast Stem Cell Epithelial-to-Mesenchymal Transition.
Mobley RJ; Raghu D; Duke LD; Abell-Hart K; Zawistowski JS; Lutz K; Gomez SM; Roy S; Homayouni R; Johnson GL; Abell AN
Cell Rep; 2017 Mar; 18(10):2387-2400. PubMed ID: 28273454
[TBL] [Abstract][Full Text] [Related]
3. A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells.
Sheta R; Woo CM; Roux-Dalvai F; Fournier F; Bourassa S; Droit A; Bertozzi CR; Bachvarov D
J Proteomics; 2016 Aug; 145():91-102. PubMed ID: 27095597
[TBL] [Abstract][Full Text] [Related]
4. Influenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication.
Nakamura S; Horie M; Daidoji T; Honda T; Yasugi M; Kuno A; Komori T; Okuzaki D; Narimatsu H; Nakaya T; Tomonaga K
J Virol; 2016 Feb; 90(4):1788-801. PubMed ID: 26637460
[TBL] [Abstract][Full Text] [Related]
5. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.
Sheta R; Bachvarova M; Macdonald E; Gobeil S; Vanderhyden B; Bachvarov D
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071912
[TBL] [Abstract][Full Text] [Related]
6. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
Schjoldager KT; Clausen H
Biochim Biophys Acta; 2012 Dec; 1820(12):2079-94. PubMed ID: 23022508
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
Balcik-Ercin P; Cetin M; Yalim-Camci I; Odabas G; Tokay N; Sayan AE; Yagci T
Cell Oncol (Dordr); 2018 Aug; 41(4):379-393. PubMed ID: 29516288
[TBL] [Abstract][Full Text] [Related]
8. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.
Chugh S; Meza J; Sheinin YM; Ponnusamy MP; Batra SK
Br J Cancer; 2016 Jun; 114(12):1376-86. PubMed ID: 27187683
[TBL] [Abstract][Full Text] [Related]
9. Generation of human bronchial epithelial cell lines expressing inactive mutants of GALNT3.
Nakamura S; Horie M; Fujino K; Matsumoto Y; Honda T; Tomonaga K
J Vet Med Sci; 2012 Nov; 74(11):1493-6. PubMed ID: 22785053
[TBL] [Abstract][Full Text] [Related]
10. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.
Barkeer S; Chugh S; Karmakar S; Kaushik G; Rauth S; Rachagani S; Batra SK; Ponnusamy MP
BMC Cancer; 2018 Nov; 18(1):1157. PubMed ID: 30466404
[TBL] [Abstract][Full Text] [Related]
11. Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome.
Peluso G; Tian E; Abusleme L; Munemasa T; Mukaibo T; Ten Hagen KG
J Biol Chem; 2020 Jan; 295(5):1411-1425. PubMed ID: 31882545
[TBL] [Abstract][Full Text] [Related]
12. GALNTs: master regulators of metastasis-associated epithelial-mesenchymal transition (EMT)?
Beaman EM; Carter DRF; Brooks SA
Glycobiology; 2022 Jun; 32(7):556-579. PubMed ID: 35312770
[TBL] [Abstract][Full Text] [Related]
13. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer.
Jordan NV; Johnson GL; Abell AN
Cell Cycle; 2011 Sep; 10(17):2865-73. PubMed ID: 21862874
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycans.
Yoshida CA; Kawane T; Moriishi T; Purushothaman A; Miyazaki T; Komori H; Mori M; Qin X; Hashimoto A; Sugahara K; Yamana K; Takada K; Komori T
J Biol Chem; 2014 Sep; 289(38):26584-26596. PubMed ID: 25107907
[TBL] [Abstract][Full Text] [Related]
15. O-glycan initiation directs distinct biological pathways and controls epithelial differentiation.
Bagdonaite I; Pallesen EM; Ye Z; Vakhrushev SY; Marinova IN; Nielsen MI; Kramer SH; Pedersen SF; Joshi HJ; Bennett EP; Dabelsteen S; Wandall HH
EMBO Rep; 2020 Jun; 21(6):e48885. PubMed ID: 32329196
[TBL] [Abstract][Full Text] [Related]
16. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
[TBL] [Abstract][Full Text] [Related]
17. Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.
Freire-de-Lima L; Gelfenbeyn K; Ding Y; Mandel U; Clausen H; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17690-5. PubMed ID: 22006308
[TBL] [Abstract][Full Text] [Related]
18. Coordinated regulation of Rel expression by MAP3K4, CBP, and HDAC6 controls phenotypic switching.
Shendy NAM; Raghu D; Roy S; Perry CH; Safi A; Branco MR; Homayouni R; Abell AN
Commun Biol; 2020 Aug; 3(1):475. PubMed ID: 32859943
[TBL] [Abstract][Full Text] [Related]
19. Expression of GALNT2 in human extravillous trophoblasts and its suppressive role in trophoblast invasion.
Liao WC; Chen CH; Liu CH; Huang MJ; Chen CW; Hung JS; Chou CH; Chen CH; Che MI; Chang HM; Lan CT; Huang HC; Tseng GF; Shyu MK; Huang MC
Placenta; 2012 Dec; 33(12):1005-11. PubMed ID: 23117232
[TBL] [Abstract][Full Text] [Related]
20. Polypeptide
Kato K; Hansen L; Clausen H
Molecules; 2021 Sep; 26(18):. PubMed ID: 34576978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
